Clinical Trials Browser

INDUSTRY × Carcinoma, Medullary × cabozantinib × Clear all

NCT01896479 2025-09-02

EXAMINER

Phase 4 Active not recruiting

247 enrolled 14 charts

Thyroid Neoplasms, Carcinoma, Medullary

NCT04211337 2025-04-20

LIBRETTO-531

Phase 3 Active not recruiting

291 enrolled 16 charts 1 FDA

Carcinoma, Medullary

NCT04760288 2024-01-05

AcceleRET-MTC

Phase 3 Withdrawn

Carcinoma, Medullary

NCT01683110 2013-01-16

Expanded Access of Cabozantinib in Medullary Thyroid Cancer

Approved for marketing

Carcinoma, Medullary